A key part of Biden's plan to combat Covid is at risk as FDA meets to debate booster shots

A key FDA panel meets Friday to debate and vote at around 2:30 p.m. ET on Pfizer and BioNTech's application to offer booster shots to the general public.

from Health and Science https://ift.tt/2Xnkgmz
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH